| HC (n = 20) | aMCI + a (n = 20) | P value |
---|---|---|---|
Demographic data | |||
Gender (male)b | 8 (40%) | 12 (60%) | 0.206 |
Age (years) | 63.85 ± 7.74 | 67.05 ± 4.67 | 0.127 |
Education (years) | 11.20 ± 3.04 | 10.80 ± 3.72 | 0.678 |
BMI | 25.55 ± 3.41 | 23.73 ± 2.41 | 0.091 |
Diabetes mellitusb | 6 (30%) | 3 (15%) | 0.256 |
Constipationb | 1 (5%) | 0 (0%) | 0.311 |
Smokingb | 1 (5%) | 0 (0%) | 0.311 |
APOE ε4b |  | 6 (30%) |  |
Amyloid Centiloid score |  | 35.20 ± 40.93 |  |
Medication | Â | Â | Â |
 Donepezilb | 0 | 12 (60%) |  |
 Rivastigmineb | 0 | 2 (10%) |  |
Neuropsychological data | |||
MMSE | 29.40 ± 0.82 | 27.00 ± 1.81 | < 0.001* |
CASI | 96.75 ± 2.66 | 88.37 ± 7.03 | < 0.001* |
CVVLT | |||
 Total | 29.65 ± 3.51 | 24.15 ± 4.91 | < 0.001* |
 Delayed | 8.80 ± 0.52 | 5.55 ± 2.67 | < 0.001* |
GDS | 1.10 ± 3.08 | 2.85 ± 1.87 | < 0.001* |
NPI | Â | Â | Â |
 Total score |  | 2.80 ± 2.65 |  |
 Behavioral composite score |  | 0.20 ± 0.41 |  |
 Affective composite score |  | 2.55 ± 2.68 |  |
 Psychotic composite score |  | 0.05 ± 0.22 |  |
DST | |||
 Forward |  | 7.70 ± 1.84 |  |
 Backward |  | 4.50 ± 1.36 |  |
VFT-animal |  | 12.50 ± 4.40 |  |
TMT-B (s) |  | 71.85 ± 32.20 |  |
FAQ |  | 4.55 ± 5.07 |  |
LQ |  | 5.40 ± 0.99 |  |